136 related articles for article (PubMed ID: 34343702)
1. The N93D mutation of the human T-cell leukemia virus type 1 envelope glycoprotein found in symptomatic patients enhances neuropilin-1 b1 domain binding.
Kusunoki H; Tanaka T; Ohshima C; Sakamoto T; Wakamatsu K; Hamaguchi I
Biochim Biophys Acta Proteins Proteom; 2021 Nov; 1869(11):140708. PubMed ID: 34343702
[TBL] [Abstract][Full Text] [Related]
2. A novel neuropilin-1-binding sequence in the human T-cell lymphotropic virus type 1 envelope glycoprotein.
Kusunoki H; Tanaka T; Kohno T; Matsuhashi K; Hosoda K; Wakamatsu K; Hamaguchi I
Biochim Biophys Acta Proteins Proteom; 2018 Apr; 1866(4):541-548. PubMed ID: 29458191
[TBL] [Abstract][Full Text] [Related]
3. Stability of the HTLV-1 glycoprotein 46 (gp46) gene in an endemic region of the Brazilian Amazon and the presence of a significant mutation (N93D) in symptomatic patients.
Socorro de Almeida Viana MND; Santos Nobre AF; Costa E; Silva IC; Pinheiro BT; Pereira CCC; de Souza Canto Ferreira L; de Almeida DS; de Araújo MWL; da Silva Borges M; da Costa CA; Ishikawa EAY; Ferrari SF; Silva de Sousa M
Virol J; 2018 May; 15(1):80. PubMed ID: 29716616
[TBL] [Abstract][Full Text] [Related]
4. Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.
Ghez D; Lepelletier Y; Lambert S; Fourneau JM; Blot V; Janvier S; Arnulf B; van Endert PM; Heveker N; Pique C; Hermine O
J Virol; 2006 Jul; 80(14):6844-54. PubMed ID: 16809290
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to the envelope glycoprotein of human T cell leukemia virus type 1 robustly activate cell-mediated cytotoxic responses and directly neutralize viral infectivity at multiple steps of the entry process.
Kuo CW; Mirsaliotis A; Brighty DW
J Immunol; 2011 Jul; 187(1):361-71. PubMed ID: 21646298
[TBL] [Abstract][Full Text] [Related]
6. HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.
Lambert S; Bouttier M; Vassy R; Seigneuret M; Petrow-Sadowski C; Janvier S; Heveker N; Ruscetti FW; Perret G; Jones KS; Pique C
Blood; 2009 May; 113(21):5176-85. PubMed ID: 19270265
[TBL] [Abstract][Full Text] [Related]
7. Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo.
Gatot JS; Callebaut I; Van Lint C; Demonté D; Kerkhofs P; Portetelle D; Burny A; Willems L; Kettmann R
J Virol; 2002 Aug; 76(16):7956-67. PubMed ID: 12134000
[TBL] [Abstract][Full Text] [Related]
8. Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin.
Jassal SR; Pöhler RG; Brighty DW
J Virol; 2001 Sep; 75(17):8317-28. PubMed ID: 11483777
[TBL] [Abstract][Full Text] [Related]
9. Interaction between the HTLV-1 envelope and cellular proteins: impact on virus infection and restriction.
Ilinskaya A; Heidecker G; Jones K
Future Med Chem; 2010 Nov; 2(11):1651-68. PubMed ID: 21428837
[TBL] [Abstract][Full Text] [Related]
10. HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding.
Kim FJ; Manel N; Garrido EN; Valle C; Sitbon M; Battini JL
Retrovirology; 2004 Dec; 1():41. PubMed ID: 15575958
[TBL] [Abstract][Full Text] [Related]
11. Soluble recombinant HTLV-1 surface glycoprotein competitively inhibits syncytia formation and viral infection of cells.
Jassal SR; Lairmore MD; Leigh-Brown AJ; Brighty DW
Virus Res; 2001 Oct; 78(1-2):17-34. PubMed ID: 11520577
[TBL] [Abstract][Full Text] [Related]
12. Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
Tezuka K; Okuma K; Kuramitsu M; Matsuoka S; Tanaka R; Tanaka Y; Hamaguchi I
J Virol; 2018 Feb; 92(4):. PubMed ID: 29212930
[TBL] [Abstract][Full Text] [Related]
13. Human T lymphotropic virus type 1 SU residue 195 plays a role in determining the preferential CD4+ T cell immortalization/transformation tropism.
Kannian P; Fernandez S; Jones KS; Green PL
J Virol; 2013 Aug; 87(16):9344-52. PubMed ID: 23785214
[TBL] [Abstract][Full Text] [Related]
14. Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.
Jones KS; Lambert S; Bouttier M; Bénit L; Ruscetti FW; Hermine O; Pique C
Viruses; 2011 Jun; 3(6):794-810. PubMed ID: 21994754
[TBL] [Abstract][Full Text] [Related]
15. Architecture and hydration of the arginine-binding site of neuropilin-1.
Mota F; Fotinou C; Rana RR; Chan AWE; Yelland T; Arooz MT; O'Leary AP; Hutton J; Frankel P; Zachary I; Selwood D; Djordjevic S
FEBS J; 2018 Apr; 285(7):1290-1304. PubMed ID: 29430837
[TBL] [Abstract][Full Text] [Related]
16. Neuropilin-1 Facilitates Pseudorabies Virus Replication and Viral Glycoprotein B Promotes Its Degradation in a Furin-Dependent Manner.
Chen M; Wang MH; Shen XG; Liu H; Zhang YY; Peng JM; Meng F; Wang TY; Bai YZ; Sun MX; Tian ZJ; Yin X; Cai XH; Tang YD
J Virol; 2022 Oct; 96(20):e0131822. PubMed ID: 36173190
[TBL] [Abstract][Full Text] [Related]
17. The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.
Jones KS; Huang YK; Chevalier SA; Afonso PV; Petrow-Sadowski C; Bertolette DC; Gessain A; Ruscetti FW; Mahieux R
J Virol; 2009 May; 83(10):5244-55. PubMed ID: 19279090
[TBL] [Abstract][Full Text] [Related]
18. Entry of human T-cell leukemia virus type 1 is augmented by heparin sulfate proteoglycans bearing short heparin-like structures.
Tanaka A; Jinno-Oue A; Shimizu N; Hoque A; Mori T; Islam S; Nakatani Y; Shinagawa M; Hoshino H
J Virol; 2012 Mar; 86(6):2959-69. PubMed ID: 22238310
[TBL] [Abstract][Full Text] [Related]
19. DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells.
Jain P; Manuel SL; Khan ZK; Ahuja J; Quann K; Wigdahl B
J Virol; 2009 Nov; 83(21):10908-21. PubMed ID: 19692463
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability.
Baek DS; Kim JH; Kim YJ; Kim YS
Mol Pharm; 2018 Feb; 15(2):394-402. PubMed ID: 29232521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
